Unmasking the Truth: The Impact of Street-Based Amphetamines on Youth and Pathways to Prevention

by Wesley Sassaman, DNP, MPH, MSN-NE, MBA, FNP-C, CARN-AP

The growing use of methamphetamine among teens and young adults is a troubling issue that threatens not only their health but also their potential and future well-being. For parents, navigating this alarming reality can seem overwhelming, yet gaining knowledge is the vital first step to making a difference. This document sheds light on the effects of methamphetamine, offering a clear picture of how this powerful stimulant impacts both the brain and body in the short and long term.

Beyond the science, it provides actionable insights into recognizing the early warning signs of use—behavioral changes, physical symptoms, and environmental clues—and explores practical strategies to intervene effectively. Whether it's through fostering open communication, leveraging prevention resources, or seeking evidence-based treatments, parents have a pivotal role in protecting their child’s future and supporting their recovery.

By better understanding the risks, signs, and available options, you can take proactive steps to safeguard your child from the devastating consequences of methamphetamine use. This guide is here to provide you with the tools, hope, and empowerment needed to face this challenge and help your teen build a brighter tomorrow.

The abuse of street-based amphetamines, particularly among teenagers and young adults, is a significant public health concern. Amphetamines, including methamphetamine and ecstasy, are synthetic stimulants that affect the central nervous system (CNS) by increasing the release of neurotransmitters such as dopamine, norepinephrine, and serotonin. These substances are known for their potent effects on mood, energy, and cognition, but they also pose serious health risks. This overview will explore the chemical composition of these drugs, their effects on the CNS, and the short- and long-term consequences of their use, as well as strategies for prevention and education.

The Science Behind Amphetamines and Their Impact on the Brain

Amphetamines, including methamphetamine, MDA, and MDMA (commonly known as ecstasy), are compounds known for their ability to significantly impact the central nervous system. These substances increase the release of monoamines, particularly dopamine, in the brain, producing effects such as heightened energy, alertness, and euphoria (Dragan et al., 2021). Their mechanism of action involves promoting dopamine release while simultaneously blocking its reuptake, which leads to higher dopamine concentrations in the synaptic cleft. This overstimulation of dopamine receptors underpins both their stimulating effects and their high addictive potential (Gibson et al., 2021). Understanding these processes is critical to addressing their use and mitigating addiction risks.

Understanding the Immediate Impact of Amphetamine Use

Short-term use of amphetamines can bring a surge in alertness, enhanced concentration, and a temporary sense of euphoria. However, these effects often come with serious risks, including heightened anxiety, paranoia, and even aggressive behavior (Hayley et al., 2023). Acute use poses significant health dangers as well, such as increased heart rate and blood pressure, which can escalate to life-threatening conditions like myocardial infarctions and arrhythmias (Sarfraz et al., 2024). The risks are further compounded when methamphetamine is combined with alcohol, as it can mask alcohol's sedative effects, leading to increased impulsivity and risk-taking behaviors (Hayley et al., 2023). Recognizing these immediate consequences is crucial in promoting safe practices and awareness.

The Lasting Impact of Chronic Amphetamine Use on Brain and Mental Health

 Long-term amphetamine use has profound effects on both neurological and mental health. Prolonged exposure to these substances can lead to neurotoxicity, primarily targeting the dopamine system. This impacts brain structure and function, resulting in impaired dopamine signaling, striatal dysfunction, and significant cognitive deficits over time (Gibson et al., 2021). Additionally, chronic amphetamine use is closely associated with increased rates of mental health disorders, including major depressive disorder, generalized anxiety disorder, and post-traumatic stress disorder. Studies show that these conditions occur more frequently in users than in non-users, highlighting the intricate and often harmful relationship between sustained amphetamine use and mental well-being (Thoradeniya et al., 2021). Recognizing these consequences is vital for offering effective support and interventions.

Prevention and Education Strategies

 Implementing educational programs in schools that focus on the risks of amphetamine use can be an effective strategy, particularly when these programs also address the social and psychological factors that contribute to drug use, such as peer pressure and mental health challenges (Asante & Atorkey, 2023). Parental involvement plays a crucial role, as increased monitoring and open communication about the dangers of drug use can significantly reduce the likelihood of amphetamine abuse among adolescents (Asante & Atorkey, 2023). Additionally, community-level interventions that bring together healthcare providers, educators, and community leaders can foster supportive environments that not only discourage drug use but also promote healthier, more positive lifestyles (Asante & Atorkey, 2023).

Key Takeaway: While amphetamines may offer short-term cognitive and mood boosts, their high potential for addiction and serious health risks cannot be ignored. The complex relationship between amphetamine use and mental health disorders highlights the need for comprehensive strategies that prioritize early intervention and ongoing support. To effectively combat amphetamine abuse—often compounded using other street drugs—it's vital to address underlying factors such as mental health challenges and social influences. Tackling these root causes is essential to reducing the prevalence of amphetamine misuse, particularly among young people.

 

Parents Beware of Silent Threats: The Deadly Link Between Marijuana, Methamphetamines, and Fentanyl in Teens and Young Adults

The prevalence of marijuana use combined with methamphetamines tainted with fentanyl among U.S. teens and young adults aged 14-25 is a complex issue influenced by various socio-economic, geographic, and demographic factors. The increasing presence of fentanyl in the illicit drug market has exacerbated the risks associated with substance use, particularly among vulnerable populations. This response synthesizes findings from multiple studies to address the prevalence, socio-economic disparities, geographic trends, demographic influences, health outcomes, and prevention strategies related to this issue.

Methamphetamine Use and Socio-Economic Inequalities: A Growing Crisis

Methamphetamine use, often combined with opioids like fentanyl, is alarmingly prevalent in low-income communities, where socio-economic disparities amplify the risks. A study from San Antonio, Texas, revealed that 19% of individuals in a low-income community reported current methamphetamine use, with strong links to lower income and residential instability (Frankeberger et al., 2024). Factors such as housing instability and restricted access to harm reduction services further exacerbate substance use, disproportionately impacting marginalized populations (Rapisarda et al., 2024). Addressing these disparities is vital to mitigating the public health impact of methamphetamine abuse in vulnerable groups.

Regional Disparities in Drug Use and Associated Risks

Geographic disparities play a significant role in the prevalence and impact of fentanyl-tainted substances, revealing distinct regional vulnerabilities. For instance, the Merrimack Valley in Massachusetts faced a severe HIV outbreak linked to injection drug use, underscoring the specific challenges certain areas face (Rapisarda et al., 2024). Studies analyzing drug concentrations further highlight these differences, showing varying levels of fentanyl and methamphetamine exposure across U.S. Census divisions. These findings point to regional variations in drug supply and usage patterns, emphasizing the importance of localized strategies to address substance use and its associated harms (Huhn et al., 2024).

Severe Health Consequences of Fentanyl-Tainted Methamphetamine Use

The health outcomes of methamphetamine use tainted with fentanyl are critically severe, marked by heightened overdose risks and complications such as infectious disease outbreaks (Rapisarda et al., 2024). A compelling case study of a 14-year-old with a severe opioid and methamphetamine use disorder further highlights the grave dangers of this issue, emphasizing the urgent need for comprehensive treatment approaches to address both the physical and psychological impacts of such substance use (Allami et al., 2024). Addressing these health risks is essential to protecting vulnerable individuals and mitigating broader public health crises.

Strengthening Prevention Efforts Through Harm Reduction and Community-Based Interventions

Effective prevention strategies are vital in combating substance use and overdose crises, with harm reduction approaches playing a key role. Initiatives such as naloxone distribution, fentanyl test strips, and supervised consumption facilities have proven to be life-saving tools in reducing overdose risks (Bolshakova et al., 2024). Equally important are community-based programs that address socio-economic disparities and ensure access to culturally appropriate healthcare, fostering more equitable and effective support systems. Together, these measures have the potential to significantly lower substance use rates and improve public health outcomes in at-risk populations (Friedman et al., 2024).

Addressing Research Gaps to Combat Youth Substance Use

The growing complexities of substance use among teens and young adults highlight critical research gaps, particularly regarding the combined use of marijuana, methamphetamines, and fentanyl. Current studies typically focus on individual substances, leaving a pressing need to understand the interactions and compounded risks of these combinations (Bolshakova et al., 2024). Equally essential is the exploration of innovative, community-based treatment models tailored to youth with substance use disorders. These approaches could pave the way for more effective interventions, reducing harm and improving outcomes for vulnerable young populations (Allami et al., 2024).

Take Home: While the prevalence of marijuana use combined with methamphetamines tainted with fentanyl is concerning, particularly in lower-income and marginalized communities, there are ongoing efforts to address these challenges through public health interventions and harm reduction strategies. However, significant gaps remain in research and policy, necessitating a comprehensive approach that considers socio-economic, geographic, and demographic factors to effectively mitigate the risks associated with these substance combinations

Use Of Bupropion ER + Long-Acting Naltrexone for Methamphetamine Use Dependence (Mud)

The combined use of bupropion and injectable naltrexone for methamphetamine use dependence (MUD) is shown promising results in recent studies. The ADAPT-2 trial, a significant study in this area, demonstrated that the combination of extended-release injectable naltrexone and extended-release oral bupropion (NTX + BUPN) significantly reduced methamphetamine use compared to placebo. This combination therapy was associated with a 27.1% increase in the probability of testing negative for methamphetamine over 12 weeks, which was significantly greater than the 11.4% increase observed in the placebo group (Li et al., 2024). This suggests that the NTX + BUPN combination could be an effective treatment for methamphetamine use disorder.

Exploring the Efficacy of NTX + BUPN in Treating Methamphetamine Use Disorder

The use of naltrexone (NTX) combined with bupropion (BUPN) has shown promising results in managing methamphetamine use disorder (MUD). Findings from the ADAPT-2 trial revealed a significant reduction in methamphetamine use, with participants receiving NTX + BUPN demonstrating a 15.8% greater increase in negative urine drug tests compared to placebo over 12 weeks (Li et al., 2024). Furthermore, a secondary analysis indicated that both men and women responded positively to this treatment, with no notable differences in efficacy between genders. Notably, hormonal contraception use among women did not impact treatment outcomes, reinforcing the consistency of results across gender lines (Levander et al., 2023). These insights highlight the potential of NTX + BUPN while paving the way for further studies to investigate gender-specific responses, considering how socio-cultural and biological factors might shape future approaches to care.

Shaping the Future of Substance Use Disorder Treatments with NTX + BUPN

The findings from the ADAPT-2 trial, which highlight the efficacy of naltrexone (NTX) and bupropion (BUPN) in reducing methamphetamine use, lay a foundation for future advancements in treating substance use disorders. These results encourage deeper exploration into the mechanisms behind their success, such as their potential to mitigate cravings and withdrawal symptoms through distinct neurobiological pathways. Additionally, while the trial showcased significant short-term benefits, further research is needed to evaluate the longevity of these effects, focusing on relapse prevention and sustained abstinence beyond the 12-week period. Integrating NTX + BUPN with complementary behavioral interventions—such as digital tools or peer support networks—could also amplify its impact, offering a more holistic approach to care and highlighting the importance of combining pharmacotherapy with psychological support (Jennings et al., 2024; Glass et al., 2023). Together, these directions pave the way for more robust and sustainable treatments for individuals battling substance use disorders.

Expanding Perspectives on NTX + BUPN in Substance Use Disorder Treatment

The promise of NTX + BUPN in addressing methamphetamine use disorder (MUD) is bolstered by findings like those from the ADAPT-2 trial, yet it is crucial to explore its role within the broader landscape of treatment options. Integrating NTX + BUPN with digital interventions, such as internet-delivered dialectical behavior therapy (iDBT) and behavioral activation, could enhance its efficacy by addressing emotional regulation and reward deficits—key factors in substance use disorders (Daros et al., 2023; Paquette et al., 2022). While generally well-tolerated, potential side effects including nausea, dizziness, and headaches, previously noted in other contexts, warrant monitoring in MUD populations (Lyu et al., 2024). Notably, the combination has demonstrated effectiveness in treating disorders like binge-eating and aiding weight loss, underscoring its versatility but also highlighting varying mechanisms and outcomes compared to MUD (McPhee, 2023; Liu et al., 2024). However, its limited impact on cocaine use disorder suggests substance-specific efficacy, emphasizing the need for continued research into long-term effects, dosage strategies, and its optimal use across various substance use disorders (Regnier et al., 2023). These insights pave the way for more personalized and comprehensive approaches in addiction treatment.

Take Home:  The combination of bupropion and injectable naltrexone (NTX + BUPN) offers significant promise as a treatment for methamphetamine use disorder (MUD). Parents should understand that the ADAPT-2 trial demonstrated its effectiveness, with a notable increase in the likelihood of patients achieving negative methamphetamine test results compared to those who received a placebo. This breakthrough suggests that NTX + BUPN could provide a critical option for individuals struggling with MUD.

However, it is important to recognize the broader considerations of treatment. While NTX + BUPN has shown success in MUD, its effectiveness may vary across different substances. For example, it has not been shown to be effective in treating cocaine use disorder, highlighting the need for tailored approaches in addressing different substance use disorders. Additionally, integrating this pharmacological treatment with behavioral therapies, such as internet-delivered dialectical behavior therapy (iDBT) or behavioral activation, could further enhance outcomes by addressing the complex emotional and psychological factors associated with addiction.

Furthermore, parents should be aware of the potential side effects of NTX + BUPN, such as nausea, dizziness, or headaches, which may require careful monitoring. Long-term outcomes, including relapse prevention and sustained abstinence, remain an area for further research, emphasizing the need for ongoing evaluation and individualized treatment plans.

Ultimately, NTX + BUPN represents a hopeful advancement in addiction treatment, but its success lies in a comprehensive approach. Combining pharmacotherapy with psychological support and closely monitoring patient responses can help ensure the best outcomes for those affected by substance use disorders. Understanding these aspects is crucial for advocating for the well-being of loved ones and supporting their recovery journeys.

Parent's Guide to Addressing Methamphetamine Use in Teens and Young Adults

Methamphetamine use among teens and young adults is a growing concern. It poses significant risks to their physical and mental health, future aspirations, and family relationships. As parents, you play a crucial role in prevention, early intervention, and support. This guide summarizes the latest research and offers strategies to help you recognize warning signs, effectively communicate with your children, and access resources for prevention and treatment.

Recognizing Warning Signs of Methamphetamine Use

Methamphetamine (often referred to as “meth”) is a highly addictive stimulant. Understanding the signs of use can help you act swiftly and appropriately. Key warning signs to look for include:

Behavioral Changes

Increased secrecy or dishonesty

Changes in sleep patterns (staying awake for long periods followed by excessive sleeping)

Withdrawal from family or long-time friends

Uncharacteristic aggression, mood swings, or paranoia

Decline in academic performance or extracurricular participation

Physical Symptoms

Sudden, unexplained weight loss

Dilated pupils and dry mouth

Unusual skin sores or excessive acne

Dental problems, such as rapid tooth decay ("meth mouth")

Hyperactivity alternating with fatigue

Psychological Indicators

Difficulty concentrating or memory problems

Anxiety, depression, or unexplained sadness

Hallucinations or paranoia

Environmental Clues

Presence of unusual items such as small plastic baggies, glass pipes, or burnt foil

Chemical smells in their room, clothing, or car

Missing money or valuables that could indicate drug purchasing

Being aware of these warning signs can help you recognize potential meth use early and provide quicker intervention.

Evidence-Based Strategies for Engaging Your Children

Approaching teens about drug use is often challenging. However, evidence-based communication can make a real difference. Here are effective strategies to start the conversation and nurture trust:

Choose the Right Time and Place

Pick a calm, private setting free from distractions.

Avoid initiating the conversation during a heated moment.

Be Empathetic and Nonjudgmental

Speak with calmness and understanding, not anger or accusation.

Use "I" statements instead of "you" statements (e.g., "I’m worried about you," instead of "You’re ruining your life").

Share Knowledge Without Fear Tactics

Use factual, research-based information about meth’s harmful effects on the body and brain.

Avoid scare tactics, which may alienate your child.

Ask Open-Ended Questions

Encourage them to share their thoughts by asking non-confrontational, open-ended questions like:

“What do you know about methamphetamine?”

“Have you seen classmates or friends using it?”

Listen without interruptions or overreacting.

Build Trust Through Support

Assure them that you are there to help, not to punish.

Highlight your shared goals for their health, happiness, and success.

Set Clear Expectations

Clearly define your family’s stance on drug use, and explain the reasoning behind these rules. For example:

“I want you to know that using methamphetamine can damage your health and your future. That’s why I don’t condone drug use.”

Model Healthy Behaviors

Maintain healthy family routines, ensure open communication, and demonstrate self-care habits as parents.

Engaging in meaningful conversations can encourage your teen to come to you for help if they are struggling.

Prevention and Supportive Resources

Providing safe environments and empowerment for your teen can significantly reduce the risk of drug use. If you suspect or confirm methamphetamine use, timely intervention and professional help are critical. Below are resources for prevention, intervention, and treatment:

Top Prevention Resources for Substance Use

Join Community Education Programs. Get involved in initiatives like the SAMHSA-supported Talk. They Hear You Campaign. These programs empower parents with tools to have open and early conversations about substance use prevention, fostering awareness and understanding within the community.

Explore Family-Based Prevention Strategies. Family programs, such as the Strengthening Families Program (SFP), provide valuable resources for parents and teens. They focus on building stronger parent-child relationships while teaching methods to reduce risky behaviors, creating a healthier and more supportive household dynamic.

Foster Mentorship and Positive Engagement. Encourage your child to participate in supervised activities like sports teams, art projects, or volunteering. These structured extracurriculars not only provide meaningful experiences but also help promote positive peer interactions and a sense of purpose, reducing the risk of substance use.

Non-Medication Intervention Strategies for Methamphetamine Use

1. Utilize Behavioral Therapies

   • Contingency Management (CM): This approach rewards individuals for abstaining from methamphetamine use, motivating consistent progress.

   • Cognitive Behavioral Therapy (CBT): Tailored CBT sessions help teens identify triggers, manage cravings, and build effective coping strategies for long-term recovery.

2. Seek Rehabilitative Support

   
   

   Explore intensive outpatient programs like the Matrix Model, which combines counseling, family therapy, and peer support groups. This holistic approach equips individuals with tools for recovery while engaging their support networks.

3. Engage with School Counselors and Peer Support

   
   

   Your school’s counselors can provide guidance and resources, while peer support groups, such as local Teens in Recovery chapters, offer encouragement, connection, and a judgment-free environment for healing.

These strategies offer valuable non-medication options to address methamphetamine use and support the road to recovery.

Comprehensive Treatment and Recovery Options for Methamphetamine Use

Effective treatment and recovery for methamphetamine use involve a blend of professional, supportive, and innovative approaches. Certified addiction treatment centers specializing in adolescent care offer tailored options, often combining behavioral therapies with medication-assisted treatments like the bupropion/naltrexone combination.

Support groups, such as Nar-Anon Family Groups, provide valuable emotional support for families, while hotlines like the SAMHSA National Helpline (1-800-662-HELP) offer round-the-clock information on treatment options and local resources.

FDA-approved tools like the reSET mobile app deliver cognitive behavioral therapy lessons to aid methamphetamine users in their recovery. Non-traditional methods, including motivational incentives, music therapy for emotional support, and repetitive transcranial magnetic stimulation (rTMS) for craving reduction, offer additional avenues for care.

Successful recovery often relies on coordinated efforts between families, schools, and healthcare providers specializing in youth addiction treatment, fostering a holistic and supportive environment for lasting healing.

Conclusion - Empowering Hope and Recovery

Recovery from methamphetamine use is not only possible but achievable with the right support, resources, and timely intervention. For parents of teens and young adults, taking action now can save your child’s life and set them on a path toward health and healing. Here are immediate steps you can take to support your child and empower their recovery:

1. Recognize the Signs and Act Early

   
   

   Stay observant for warning signs such as sudden behavioral changes, physical symptoms like unexplained weight loss, or environmental clues such as unusual objects like small baggies or burnt foil. Acting swiftly when these signs arise can help prevent further harm.

2. Foster an Open and Safe Environment

   
   

   Create a judgment-free space where your child feels safe to talk. Approach them with empathy, using calm, non-confrontational language. Say things like, “I’m here to support you, no matter what,” to reinforce your role as their ally.

3. Seek Professional Support Immediately

   
   

   Contact certified addiction treatment centers, particularly those that specialize in adolescent care. Their expertise in behavioral therapies and medication-assisted treatments, like bupropion/naltrexone combinations, can create a tailored recovery plan for your child.

4. Leverage Community and Peer Resources

   
   

   Explore support groups such as Nar-Anon Family Groups, which provide emotional guidance for families. Additionally, foster connections with local peer programs like Teens in Recovery, where your child can engage with others who understand their struggles.

5. Implement Behavioral and Therapeutic Interventions

   
   

   Consider evidence-based approaches like Cognitive Behavioral Therapy (CBT) or Contingency Management programs, which focus on developing coping strategies and rewarding abstinence. Intensive outpatient programs, such as the Matrix Model, offer a holistic process that integrates family therapy and peer support.

6. Equip Yourself with Emergency Tools

   
   

   Access harm reduction tools such as fentanyl test strips or naloxone kits, potentially life-saving resources in the case of overdose. Stay informed about supervised consumption facilities or other community-based harm reduction measures.

7. Prioritize Self-Care and Family Stability

   
   

   Supporting a child in recovery is emotionally challenging. Prioritize your own well-being by seeking counseling and building a support network. A healthy and stable environment strengthens the foundation for your child’s recovery.

By taking these steps, you’re not just helping your child fight methamphetamine use; you’re showing them that recovery is a shared journey you’ll face together. Your willingness to act, combined with professional and community support, provides the hope and tools your child needs to reclaim their future. Remember, progress may take time, but each small step towards healing is a victory worth celebrating. Never lose sight of the resilience and potential within your child, as with love and determination, recovery is within reach.

The closing section is ready and filled with hope and actionable steps for parents. Let me know if there's anything else you'd like to refine or add! Stay connected and informed! Follow me on LinkedIn for more insights, or explore my in-depth blog posts at wesleysassaman.com. Let’s continue the conversation!

 References

Asante, K. O., & Atorkey, P. (2023). Cannabis and amphetamine use among school-going adolescents in sub-Saharan Africa: A multi-country analysis of prevalence and associated factors. BMC Psychiatry, 23.

Bolshakova, M., Simpson, K. A., Ganesh, S. S., Goldshear, J. L., Page, C. M., & Bluthenthal, R. N. (2024). "The fentanyl made me feel like I needed more methadone”: Changes in the role and use of medication for opioid use disorder (MOUD) due to fentanyl. Harm Reduction Journal, 21(1).

Daros, A. R., Guimond, T. H., Yager, C., Palermo, E. H., Wilks, C. R., & Quilty, L. C. (2023). Feasibility, acceptability, and potential efficacy of a self-guided, Internet-delivered dialectical behavior therapy intervention for substance use disorders: A randomized controlled trial. (Preprint). JMIR Mental Health. 

Dragan, A.-M., Parrilla, M., Feier, B., Oprean, R., Cristea, C., & De Wael, K. (2021). Analytical techniques for the detection of amphetamine-type substances in different matrices: A comprehensive review. Trends in Analytical Chemistry, 145, 116447.

Frankeberger, J., Perdue, T., Ramírez, E., Valdez, A., & Cepeda, A. (2024). Correlates of current methamphetamine use and opioid co-use among Latina women in a low-income community. Journal of Psychoactive Drugs, 1–10.

Friedman, J., Tiako, M. J. N., & Hansen, H. (2024). Understanding and addressing widening racial inequalities in drug overdose. American Journal of Psychiatry, 181(5), 381–390.

Gibson, A., West, P. J., & Keefe, K. A. (2021). Effects of methamphetamine-induced neurotoxicity on striatal long-term potentiation. Psychopharmacology, 239(1), 93–104. 

Glass, J. E., Dorsey, C. N., Beatty, T., Bobb, J. F., Wong, E. S., Palazzo, L., King, D. A., Mogk, J., Stefanik-Guizlo, K., Idu, A. E., Key, D., Fortney, J. C., Cooper Thomas, R., Garza McWethy, A., Caldeiro, R. M., & Bradley, K. A. (2023). Study protocol for a factorial-randomized controlled trial evaluating the implementation, costs, effectiveness, and sustainment of digital therapeutics for substance use disorder in primary care (DIGITS Trial). Implementation Science, 18(1).

Hayley, A. C., Shiferaw, B., & Downey, L. A. (2023). Acute neurocognitive and subjective effects of oral methamphetamine with low doses of alcohol: A randomized controlled trial. Journal of Psychopharmacology. 

Huhn, A. S., Whitley, P., Bolin, B., & Dunn, K. E. (2024). Fentanyl, heroin, methamphetamine, and cocaine analyte concentrations in urine drug testing specimens. JAMA Network Open, 7(10), e2441063–e2441063.

Jennings, L. K., Lander, L., Lawdahl, T., McClure, E. A., Moreland, A., McCauley, J. L., Haynes, L., Matheson, T., Jones, R., Robey, T. E., Kawasaki, S., Moschella, P., Raheemullah, A., Miller, S., Gregovich, G., Waltman, D., Brady, K. T., & Barth, K. S. (2024). Characterization of peer support services for substance use disorders in 11 US emergency departments in 2020: Findings from a NIDA clinical trials network site selection process. Addiction Science & Clinical Practice, 19.

Levander, X. A., Carmody, T. J., Cook, R., Potter, J. S., Trivedi, M. H., Korthuis, P. T., & Shoptaw, S. (2023). A gender-based secondary analysis of the ADAPT-2 combination naltrexone and bupropion treatment for methamphetamine use disorder trial. Addiction, 118(7), 1320–1328.

Li, M. J., Chau, B., Belin, T. R., Carmody, T., Jha, M. K., Marino, E. N., Trivedi, M. H., & Shoptaw, S. (2024). Extended observation of reduced methamphetamine use with combined naltrexone plus bupropion in the ADAPT-2 trial. Addiction. Wiley-Blackwell.

Liu, Y., Han, F., Sun, P., Rohani, P., Amirthalingam, P., & Sohouli, M. (2024). The effects of bupropion alone and combined with naltrexone on weight loss: A systematic review and meta-regression analysis of randomized controlled trials. Diabetology & Metabolic Syndrome, 16.

Lyu, Y. S., Ahn, H. Y., Hong, S., & Park, C. Y. (2024). Safety and effectiveness of naltrexone-bupropion in Korean adults with obesity: Post-marketing surveillance study. Drug Design, Development and Therapy, 18. Dove Medical Press.

McPhee, J. (2023). Naltrexone plus bupropion combination medication maintenance treatment for binge-eating disorder following successful acute treatments: Randomized double-blind placebo-controlled trial. Psychological Medicine, 1–10.

Paquette, C. E., Reese, E. D., Yi, J. Y., MacCarone, J. M., Stewart, Z. J., & Daughters, S. B. (2022). Group behavioral activation with and without a smartphone app in intensive outpatient treatment for substance use disorder: A three-arm randomized controlled trial. Drug and Alcohol Dependence, 243, 109758. 

Rapisarda, S. S., Silcox, J., Case, P., Palacios, W. R., Stopka, T. J., Zaragoza, S., Hughto, J. M. W., Shrestha, S., & Green, T. C. (2024). Rapid assessment amid an injection drug use-driven HIV outbreak in Massachusetts’ Merrimack Valley: Highlights from a case study. AIDS and Behavior.

Sarfraz, Z., Jain, L., Shahzad, A., & Sabzwari, S. R. A. (2024). Abstract 4147796: Cardiovascular manifestations of amphetamine misuse: A pooled analysis. Circulation, 150(Suppl_1).

Shufflebarger, E. F., Reynolds, L., McNellage, L., Booth, J., Brown, J., Edwards, A., Li, L., Robinett, D. A., & Walter, L. A. (2024). Fentanyl-positive urine drug screens in the emergency department: Association with intentional opioid misuse and racial disparities. Drug and Alcohol Dependence, 12, 100269–100269.

Thoradeniya, M. R., Wessel, E. L., Pourmarzi, D., Najman, J. M., & Smirnov, A. (2021). The prevalence of mental health disorders among young adults who use amphetamine-type stimulants, compared to young adults who do not. Drug and Alcohol Review, 40(4), 557–566.

About the Authors

Wesley Sassaman, DNP, is a medical professional with years of experience in addiction and mental health. Working on the front lines of the fentanyl epidemic, Dr. Sassaman is dedicated to empowering families affected by fentanyl addiction by providing them with the knowledge and resources to navigate the difficult road to recovery. With a deep understanding of the biopsychosocial model of addiction, Dr. Sassaman combines expert insights with compassionate guidance, offering

hope to those struggling with the devastating effects of street-based fentanyl addiction. This essential guidebook invites readers into a transformative conversation, bridging the gap between despair and hope while illuminating a path toward healing and resilience.